ANI PHARMACEUTICALS INC - COM (ANIP)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
13.8 M
Holdings value Q1 2024
$955 M
Value change Q1 2024
+$35.9 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
191
Number of buys Q1 2024
100
Number of sells Q1 2024
-74
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
00182C103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 13.8 M $955 M +$35.9 M $69.13 192
2023 Q4 13.4 M $736 M +$14.4 M $55.14 176
2023 Q3 13.2 M $764 M +$50.1 M $58.06 182
2023 Q2 12.3 M $661 M +$105 M $53.83 166
2023 Q1 10.3 M $411 M +$7.05 M $39.72 135
2022 Q4 10.2 M $412 M +$3.08 M $40.23 124
2022 Q3 10.2 M $329 M +$12.8 M $32.14 113
2022 Q2 9.84 M $292 M +$29.9 M $29.67 106
2022 Q1 9.16 M $258 M -$5.7 M $28.11 112
2021 Q4 8.88 M $409 M +$81.9 M $46.08 122
2021 Q3 7.26 M $238 M +$15.3 M $32.82 105
2021 Q2 7.21 M $252 M -$2.82 M $35.05 106
2021 Q1 7.29 M $263 M -$828 K $36.14 101
2020 Q4 7.31 M $212 M +$2.53 M $29.04 108
2020 Q3 7.26 M $205 M -$7.68 M $28.21 101
2020 Q2 7.27 M $235 M -$25.7 M $32.34 117
2020 Q1 7.93 M $323 M -$12.4 M $40.74 133
2019 Q4 8.07 M $498 M -$71 M $61.67 161
2019 Q3 9.1 M $663 M +$37.9 M $72.88 183
2019 Q2 8.56 M $704 M +$78.9 M $82.20 188
2019 Q1 7.47 M $527 M +$37.9 M $70.54 179
2018 Q4 7.08 M $319 M -$17.8 M $45.02 155
2018 Q3 7.46 M $422 M +$13.6 M $56.54 163
2018 Q2 7.18 M $480 M +$21 M $66.80 178
2018 Q1 6.62 M $386 M +$5.07 M $58.22 168
2017 Q4 6.54 M $422 M +$7.87 M $64.45 154
2017 Q3 6.38 M $335 M -$1.91 M $52.49 135
2017 Q2 6.42 M $301 M +$685 K $46.80 142
2017 Q1 6.44 M $319 M +$59.8 M $49.51 151
2016 Q4 6.23 M $378 M +$11.1 M $60.62 151
2016 Q3 5.97 M $396 M +$26.7 M $66.35 163
2016 Q2 5.6 M $312 M +$11.6 M $55.82 137
2016 Q1 5.8 M $195 M -$21.5 M $33.66 116
2015 Q4 6.32 M $285 M -$30.5 M $45.12 120
2015 Q3 6.97 M $275 M +$16.6 M $39.51 119
2015 Q2 6.39 M $396 M -$29.9 M $62.05 123
2015 Q1 6.96 M $435 M +$84.6 M $62.55 127
2014 Q4 5.63 M $317 M +$99.2 M $56.39 99
2014 Q3 4.53 M $129 M -$3.21 M $28.28 69
2014 Q2 4.49 M $155 M +$28.4 M $34.44 78
2014 Q1 3.76 M $118 M +$77.6 M $31.35 64